M
39
9
RIG
61
3
NUE
68
17
NTAP
59
5
HAL
57
10
MAR
69
13
COST
57
3
T
42
3
AFL
44
3
RRC
58
8
WBA
48
-5
CNX
75
6
PBI
63
4
MSI
66
3
ITW
70
6
PYPL
49
8
KR
52
8
MHK
52
7
GE
65
4
BRK.B
42
15
M
39
9
RIG
61
3
NUE
68
17
NTAP
59
5
HAL
57
10
MAR
69
13
COST
57
3
T
42
3
AFL
44
3
RRC
58
8
WBA
48
-5
CNX
75
6
PBI
63
4
MSI
66
3
ITW
70
6
PYPL
49
8
KR
52
8
MHK
52
7
GE
65
4
BRK.B
42
15
Financhill
Back

GoodRx Holdings 10K Form

Sell
34

GDRX
GoodRx Holdings

Last Price:
5.02
Seasonality Move:
-6.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GDRX News And Ratings

See the #1 stock for the next 7 days that we like better than GDRX

GDRX Financial Statistics

Sales & Book Value

Annual Sales: $750.27M
Cash Flow: $-7.53M
Price / Cash Flow: 36.89
Annual Sales: $1.77
Price / Book: 3.37

Profitability

EPS (TTM): -0.13260
Net Income (TTM): $-58.68M
Gross Margin: $683.34M
Return on Equity: -7.64%
Return on Assets: -3.71%

GoodRx Holdings Earnings Forecast

Key GoodRx Holdings Financial Ratios

  • The Gross Profit Margin over the past 6 years for GDRX is 91.08%.
  • The Selling, General & Administrative Expenses for GDRX have been equal to 62.22% of Gross Profit Margin.
  • The Research & Development expenses have been 18.11% of Revenue.
  • The Interest Expense is -639.69% of Operating Income.
  • The Net Earning history of GDRX is -1.18% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

GoodRx Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: GDRX
Website: goodrx.com

Debt

Debt-to-Equity Ratio: 0.98
Current Ratio: 7.32
Quick Ratio: 6.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 13.48

GDRX Technical Analysis vs Fundamental Analysis

Sell
34
GoodRx Holdings (GDRX) is a Sell

Is GoodRx Holdings a Buy or a Sell?

  • GoodRx Holdings stock is rated a Sell
    The current GoodRx Holdings [GDRX] share price is $6.10. The Score for GDRX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.